References:
  1. Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab . 2020;105(7):dgaa276. doi:10.1210/clinem/dgaa276
  2. Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones (Athens) . 2021;20(1):219-221. doi:10.1007/s42000-020-00230-w
  3. Passah A, Arora S, Damle NA, Reddy KS, Khandelwal D, Aggarwal S. Occurrence of Subacute Thyroiditis following Influenza Vaccination [published correction appears in Indian J Endocrinol Metab. 2018 Nov-Dec;22(6):867]. Indian J Endocrinol Metab . 2018;22(5):713-714. doi:10.4103/ijem.IJEM_237_18
  4. Girgis CM, Russo RR, Benson K. Subacute thyroiditis following the H1N1 vaccine. J Endocrinol Invest . 2010;33(7):506. doi:10.1007/BF03346633
  5. Ella R, Reddy S, Jogdand H, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial [published online ahead of print, 2021 Mar 8]. Lancet Infect Dis . 2021;S1473-3099(21)00070-0. doi:10.1016/S1473-3099(21)00070-0